癌症疼痛在整个生存过程中仍然非常普遍且持续存在，因此研究利用移动健康 (mHealth) 应用程序的先进功能使个人能够自我管理疼痛的潜力至关重要。 本次综述旨在全面了解移动医疗应用程序在支持癌痛自我管理方面的可接受性、用户体验和有效性。 我们按照 Souza 和 Whittemore 以及 Knafl 的 6 项审查​​流程进行了综合审查。在 PubMed、Scopus、CINAHL Plus with Full Text、PsycINFO 和 Embase 中检索了 2013 年至 2023 年的文献。关键词包括“癌症患者”、“疼痛”、“自我管理”、“移动医疗应用”和相关同义词在搜索中使用。约翰·霍普金斯大学的研究证据评估工具用于评估合格研究的质量。进行叙述综合来分析提取的数据。 总共纳入 20 项研究，总体质量评级为高（n=15）至良好（n=5）。对于大多数癌症患者来说，使用移动医疗应用程序来监测和管理疼痛是可以接受的。 mHealth 在测量疼痛方面的内部一致性为 0.96。报告的每日评估或参与率范围为 61.9% 至 76.8%。所有移动医疗应用程序都是为多模式干预而设计的。参与者普遍对疼痛应用程序有积极的体验，认为它们令人愉快且用户友好。此外，6 项研究报告了健康结果的显着改善，包括疼痛缓解（严重程度和强度）的增强、药物依从性以及突发性疼痛频率的降低。移动医疗应用程序最常强调的作用包括疼痛监测、跟踪、提醒、教育促进和支持协调。 移动医疗应用程序在支持疼痛自我管理方面是有效且可接受的。他们为患者提供了一种有前途的多模型方法来监测、跟踪和管理他们的疼痛。这些发现为利用移动医疗应用程序支持癌痛自我管理提供了基于证据的见解。需要更多高质量的研究来检验基于数字技术的癌症疼痛自我管理干预措施的有效性，并确定其在现实世界实践中实施的促进因素和障碍。©Weizi Wu、Teresa Graziano、Andrew Salner、Ming -陈辉、Michelle P Judge、丛晓梅、徐万里。最初发表于 JMIR mHealth 和 uHealth (https://mhealth.jmir.org)，2024 年 7 月 18 日。

 Cancer pain remains highly prevalent and persistent throughout survivorship, and it is crucial to investigate the potential of leveraging the advanced features of mobile health (mHealth) apps to empower individuals to self-manage their pain. This review aims to comprehensively understand the acceptability, users' experiences, and effectiveness of mHealth apps in supporting cancer pain self-management. We conducted an integrative review following Souza and Whittemore and Knafl's 6 review processes. Literature was searched in PubMed, Scopus, CINAHL Plus with Full Text, PsycINFO, and Embase, from 2013 to 2023. Keywords including "cancer patients," "pain," "self-management," "mHealth applications," and relevant synonyms were used in the search. The Johns Hopkins research evidence appraisal tool was used to evaluate the quality of eligible studies. A narrative synthesis was conducted to analyze the extracted data. A total of 20 studies were included, with the overall quality rated as high (n=15) to good (n=5). Using mHealth apps to monitor and manage pain was acceptable for most patients with cancer. The internal consistency of the mHealth in measuring pain was 0.96. The reported daily assessment or engagement rate ranged from 61.9% to 76.8%. All mHealth apps were designed for multimodal interventions. Participants generally had positive experiences using pain apps, rating them as enjoyable and user-friendly. In addition, 6 studies reported significant improvements in health outcomes, including enhancement in pain remission (severity and intensity), medication adherence, and a reduced frequency of breakthrough pain. The most frequently highlighted roles of mHealth apps included pain monitoring, tracking, reminders, education facilitation, and support coordination. mHealth apps are effective and acceptable in supporting pain self-management. They offer a promising multi-model approach for patients to monitor, track, and manage their pain. These findings provide evidence-based insights for leveraging mHealth apps to support cancer pain self-management. More high-quality studies are needed to examine the effectiveness of digital technology-based interventions for cancer pain self-management and to identify the facilitators and barriers to their implementation in real-world practice.©Weizi Wu, Teresa Graziano, Andrew Salner, Ming-Hui Chen, Michelle P Judge, Xiaomei Cong, Wanli Xu. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 18.07.2024.